These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 19228615)
21. Dispute over use of MDs' prescribing information heading to court. Sibbald B CMAJ; 2003 Feb; 168(3):325. PubMed ID: 12566344 [No Abstract] [Full Text] [Related]
22. Marketing pharmaceuticals: a constitutional right to sell prescriber-identified data? Gostin LO JAMA; 2012 Feb; 307(8):787-8. PubMed ID: 22357827 [No Abstract] [Full Text] [Related]
23. The tobacco industry and the First Amendment: an analysis of the 1998 Master Settlement Agreement. Luka LA J Law Health; 1999-2000; 14(2):297-319. PubMed ID: 11499160 [No Abstract] [Full Text] [Related]
24. Drug marketing exclusivity under United States and European Union law. Junod V Food Drug Law J; 2004; 59(4):479-518. PubMed ID: 15875347 [No Abstract] [Full Text] [Related]
25. Legalized importation of Canadian prescription drugs: short-term solution to a long-term problem. Teufel AT J Contemp Health Law Policy; 2006; 22(2):383-408. PubMed ID: 17117702 [No Abstract] [Full Text] [Related]
26. Where does drug importation stand now? Guglielmo WJ Med Econ; 2005 Mar; 82(6):42, 44, 46. PubMed ID: 15869085 [No Abstract] [Full Text] [Related]
28. Not as easy as it may appear: using radio frequency identification technology to fulfill the Prescription Drug Marketing Act's elusive pedigree requirement. Asamoah AK Food Drug Law J; 2006; 61(2):385-418. PubMed ID: 16903035 [No Abstract] [Full Text] [Related]
30. Mandatory genetic dogtags and the Fourth Amendment: the need for a new post-Skinner test. Scherer RC Georgetown Law J; 1997 Jun; 85(6):2007-38. PubMed ID: 16523576 [No Abstract] [Full Text] [Related]
31. Off-label or off-limits? Ratner M; Gura T Nat Biotechnol; 2008 Aug; 26(8):867-75. PubMed ID: 18688236 [No Abstract] [Full Text] [Related]
32. Constitutional protection of scientific and educational activities from tort liability: the first amendment as a defense to personal injury litigation. Beck JM Tort Insur Law J; 2002; 37(3):981-98. PubMed ID: 12118484 [No Abstract] [Full Text] [Related]
33. Why States should ban the sale of physician prescribing data. Schaefer BM; Rising J; Grande D; Silver-Isenstadt J; J Ambul Care Manage; 2007; 30(3):206-8. PubMed ID: 17581431 [No Abstract] [Full Text] [Related]
34. Physicians discuss use of prescribing data. Kaplan DS; Fujita WH W V Med J; 2009; 105(2):52-3. PubMed ID: 19271700 [No Abstract] [Full Text] [Related]
35. The reach of free speech: recent rulings make it tough to nail down the boundaries of protected speech and other thorny state-federal issues. Savage DG State Legis; 2011; 37(9):26-9. PubMed ID: 22069842 [No Abstract] [Full Text] [Related]
36. Marketing drugs: debating the real cost. Concern about close ties between doctors and pharmaceutical firms are prompting new financial disclosure laws and education efforts. Brand R State Legis; 2008 Sep; 34(8):26-9. PubMed ID: 18754159 [No Abstract] [Full Text] [Related]
37. Prescription data mining and the protection of patients' interests. Orentlicher D J Law Med Ethics; 2010; 38(1):74-84. PubMed ID: 20446986 [TBL] [Abstract][Full Text] [Related]
38. The end of privacy. Rubenfeld J Stanford Law Rev; 2008 Oct; 61(1):101-62. PubMed ID: 19031656 [No Abstract] [Full Text] [Related]
39. Alberta delivers new blow to prescription data mining. Dunleavy N CMAJ; 2003 Apr; 168(9):1169. PubMed ID: 12719332 [No Abstract] [Full Text] [Related]
40. Predictable materiality: a need for common criteria governing the disclosure of clinical trial results by publicly-traded pharmaceutical companies. Cohen K; Cormier JW; Davar MV J Contemp Health Law Policy; 2013; 29(2):201-32. PubMed ID: 23837261 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]